Inventor · disambiguated record
Peng Huang
Also filed as: HUANG PENG · HUANG PENG-NIEN
8 granted patents·11 pending applications·3 citations·filing 2001–2025
76Inventor score
Top patents by PatentIndex Score
19 records- 0180US10987373B2DNA origami nanostructures for treatment of acute kidney injuryYAN HAO·Filed 2018·Granted Apr 27, 2021·2 cites·8 claims
- 0276US12310960B2Combinational uses of nitroxoline and its analogues with chemotherapies and immunotherapies in the treatment of cancersJIANGSU YAHONG MEDITECH CO LTD·Filed 2022·Granted May 27, 2025·0 cites·9 claims
- 0376US12171754B2Combinational uses of nitroxoline and its analogues with chemotherapies and immunotherapies in the treatment of cancersJIANGSU YAHONG MEDITECH CO LTD·Filed 2022·Granted Dec 24, 2024·0 cites·5 claims
- 0476US2025248988A1Combination uses of nitroxoline and its analogues with chemotherapies and immunotherapies in the treatment of cancersJIANGSU YAHONG MEDITECH CO LTD·Filed 2025·Application pending·0 cites
- 0575US2024366167A1Lung cancer predictionUNIV JOHNS HOPKINS·Filed 2024·Application pending·0 cites
- 0667US10316361B2Genome-wide methylation analysis and use to identify genes specific to breast cancer hormone receptor status and risk of recurrenceSUKUMAR SARASWATI V·Filed 2012·Granted Jun 11, 2019·1 cites·10 claims
- 0763US11679102B2Method for inhibiting virus infection and replicationUNIV CHANG GUNG·Filed 2021·Granted Jun 20, 2023·0 cites·3 claims
- 0862US12059284B2Lung cancer predictionUNIV JOHNS HOPKINS·Filed 2020·Granted Aug 13, 2024·0 cites·20 claims
- 0959US11324739B2Combinational uses of nitroxoline and its analogues with chemotherapies and immunotherapies in the treatment of cancersJIANGSU YAHONG MEDITECH CO LTD·Filed 2017·Granted May 10, 2022·0 cites·4 claims
- 1058US2021322453A1Dna origami nanostructures for treatment of acute kidney injuryYAN HAO·Filed 2021·Application pending·0 cites
- 1156US2025090823A1Microneedle patch for enhancing accumulation of protoporphyrin ix in solid tumor and preparation method thereforUNIV SHENZHEN·Filed 2022·Application pending·0 cites
- 1252US2021386726A1Method for inhibiting coronavirus infection and replicationUNIV CHANG GUNG·Filed 2020·Application pending·0 cites
- 1352US2021386725A1Method for inhibiting coronavirus infection and replicationUNIV CHANG GUNG·Filed 2020·Application pending·0 cites
- 1450US12467926B2Method for determining immune competence against severe acute respiratory syndrome coronavirus 2UNIV CHANG GUNG·Filed 2021·Granted Nov 11, 2025·0 cites·4 claims
- 1548US2006058383A1Propyl 3-bromo-2-oxopropionate and derivatives as novel anticancer agentsHUANG PENG·Filed 2005·Application pending·0 cites
- 1646US2005004044A1Use of orsaponin [3beta, 16beta, 17 alpha-trihydroxycholost-5-en-22-one 16-0-(2-0-4-methoxybenzoyl-beta-D-xylopyranosyl)-(1->3)-(2-0-acetyl-alpha-L-arabinopyranoside)] or OSW-1 and its derivatives for cancer therapeuticsREGENTS BOARD OF·Filed 2004·Application pending·0 cites
- 1744US2004161408A1Uses of circadian gene mPer2Filed 2003·Application pending·0 cites
- 1844US2002106348A1Cancer therapeutics involving the administration of 2-methoxyestradiol and an agent that increases intracellular superoxide anionFiled 2001·Application pending·0 cites
- 1942US2014030260A1Methods and compositions to eliminate chronic lymphocytic leukemia and other hematologic malignant cells in stromal microenvironment for cancer therapyHUANG PENG·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peng Huang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →